Trial Profile
A Phase 1, Randomized, Double-blinded, Four-period Crossover, Thorough QT/QTC (TQT) Clinical Trial to Evaluate the Effect of Zoliflodacin on Cardiac Repolarization in Healthy Male and Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Oct 2021
Price :
$35
*
At a glance
- Drugs Zoliflodacin (Primary) ; Moxifloxacin
- Indications Gonorrhoea
- Focus Adverse reactions
- 04 Oct 2021 Primary endpoint has been met. (The One-sided 95% Confidence Interval (CI) for the Largest Time-matched, Placebo-corrected, Baseline-adjusted Mean QTcF Interval (Delta Delta QTcF) Following Administration of Zoliflodacin)
- 04 Oct 2021 Results published in the Antimicrobial Agents and Chemotherapy
- 10 Jan 2019 Status changed from active, no longer recruiting to completed.